Melvin, AJ, Yee, KL, Gray, KP, Yedla, M, Wan, H, Tobin, NH, Teppler, H, Campbell, H, McCarthy, K, Scheckter, R, Aurpibul, L, Ounchanum, P, Rungmaitree, S, Cassim, H, McFarland, E
, Flynn, P, Cooper, E, Krotje, C, Townley, E, Moye, J, Best, BM, Beck, J, Sise, T, Kapogiannis, BG, George, K, Morgan, P, Woolwine-Cunningham, Y, Leblanc, R, Trabert, K, Mendell, J, Alvero, C, Farhad, M, Pasyar, S, Muresan, P, Patel, N, English, A, Heince, R, Jones, S, McLaud, D, Hays, SC, Dunn, J, Navarro, K, Robson, A, Ndiwani, H, Mathiba, R, Violari, A, Ramsagar, N, Chotirosniramit, N, Khamrong, C, Jantong, J, Cressy, TR, Sukrakanchana, PO, Thaweesombat, Y, Kaewmamuang, K, Vanprapar, N, Chokephaibulkit, K, Kongstan, N & Lermankul, W 2023, '
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living with HIV: Week 24 Results from IMPAACT 2014',
Journal of Acquired Immune Deficiency Syndromes, vol. 92, no. 2, pp. 153-161.
https://doi.org/10.1097/QAI.0000000000003116